Quest Diagnostics Declares Quarterly Cash Dividend
Quest Diagnostics (NYSE: DGX), a leading diagnostic information services provider, has announced a quarterly cash dividend.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Quest Diagnostics (NYSE: DGX), a leading diagnostic information services provider, has announced a quarterly cash dividend. The company's Board of Directors has declared a dividend of $0.80 per share. The dividend will be paid on October 20, 2025, to shareholders who hold Quest Diagnostics common stock as of the record date of October 3, 2025.
Details
News Market Reaction – DGX
On Aug 14, the first trading day after this news, DGX closed 0.34% below the previous close.
Data tracked by StockTitan Argus for the Aug 14 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
About Quest Diagnostics
Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to take action to improve health outcomes. Derived from one of the world's largest databases of de-identifiable clinical lab results, Quest's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the
View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-declares-quarterly-cash-dividend-302529498.html
SOURCE Quest Diagnostics
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.